Please select the option that best describes you:

Given RADICALS-HD, are you completing 24 mo vs 6 mo of ADT with XRT following RP?  

RADICALS-HD trial (ESMO 2022) demonstrated metastasis free survival benefit with 24 months compared to 6 months of ADT.



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Tennessee Oncology
I too await the full manuscript, which I hope will...
Radiation Oncologist at Kansas City VA Medical Center
I look at several prognostic factors, most importa...
Radiation Oncologist at Kansas City VA Medical Center
Parker reported no meaningful difference among thr...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more